Debt-to-equity of Dyne Therapeutics, Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Dyne Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Dyne Therapeutics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 21%, a 143% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Dyne Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 21% +12% +143% 31 Dec 2025
Q3 2025 17% +6.1% +54% 30 Sep 2025
Q2 2025 13% -1.8% -12% 30 Jun 2025
Q1 2025 8.2% -15% -65% 31 Mar 2025
Q4 2024 8.5% -23% -73% 31 Dec 2024
Q3 2024 11% -12% -51% 30 Sep 2024
Q2 2024 15% -5.7% -28% 30 Jun 2024
Q1 2024 23% +3.5% +18% 31 Mar 2024
Q4 2023 32% +13% +71% 31 Dec 2023
Q3 2023 23% +6.2% +36% 30 Sep 2023
Q2 2023 21% +5.3% +35% 30 Jun 2023
Q1 2023 20% +8.5% +76% 31 Mar 2023
Q4 2022 18% +10% +129% 31 Dec 2022
Q3 2022 17% +12% +214% 30 Sep 2022
Q2 2022 15% +12% +367% 30 Jun 2022
Q1 2022 11% 31 Mar 2022
Q4 2021 8.1% 31 Dec 2021
Q3 2021 5.4% 30 Sep 2021
Q2 2021 3.3% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.